RNA POL II POLY-A SITE AND 3' TERMINATION

RNA POL II POLY-A 位点和 3 终止

基本信息

项目摘要

It is the long term general objective of this proposal and of my laboratory to understand gene regulation through poly(A) site use in complex transcription units. For all pol II transcription units, 3' end formation and transcription termination are mandatory steps in mRNA biosynthesis and in the definition of the transcription unit. As we are defining gene regulation by 3' end processing, we are necessarily also considering how 3' end processing affects i.) pol II transcription termination ii.) splice site recognition and utilization and iii.) transport of mRNA from the nucleus to the cytoplasm. Each of these steps is recognized as playing an increasingly large role in the strategy of eucaryotic gene regulation. The specific goal of this research plan is to extend our characterization of the molecular biology and biochemistry of 3' end formation and transcription termination in RNA pol II transcription units. We are characterizing regulation of poly(A) site use in tandem poly(A) site containing transcription units to understand how poly(A) site choice is determined for complex transcription units. These studies necessarily require a comparison to function of individual poly(A) sites. The efficiency of 3' processing for a given substrate pre-mRNA is a major focus of these studies since it is a key determinant in alternative processing as well as in transcription termination. We have shown that recognition and presumably cleavage efficiency at the poly(A) site is a required first step in formation of a "termination competent" RNA polymerase II elongation complex. We are extending our characterization of 3' processing to a characterization of how 3' processing causes formation of the termination competent elongation complex. We are pursuing two parallel and complementing strategies for characterization of 3' processing and transcription termination; i. in vivo studies which we are using to identify functional parameters which are operating to regulate 3' processing and termination within the cell ii. in vitro studies defining the biochemistry of 3'processing and transcription termination.
这是本建议和我本人的长期总体目标

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sequence-mediated regulation of adenovirus gene expression by repression of mRNA accumulation.
通过抑制 mRNA 积累来序列介导的腺病毒基因表达调控。
  • DOI:
    10.1128/mcb.17.4.2207
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Prescott,JC;Liu,L;Falck-Pedersen,E
  • 通讯作者:
    Falck-Pedersen,E
3' RNA processing efficiency plays a primary role in generating termination-competent RNA polymerase II elongation complexes.
3 RNA 加工效率在生成具有终止能力的 RNA 聚合酶 II 延伸复合物中起主要作用。
  • DOI:
    10.1128/mcb.13.6.3472-3480.1993
  • 发表时间:
    1993
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Edwalds-Gilbert,G;Prescott,J;Falck-Pedersen,E
  • 通讯作者:
    Falck-Pedersen,E
Varied poly(A) site efficiency in the adenovirus major late transcription unit.
腺病毒主要晚期转录单位中不同的聚腺苷酸位点效率。
Sequences regulating temporal poly(A) site switching in the adenovirus major late transcription unit.
调节腺病毒主要晚期转录单位中时间性 Poly(A) 位点转换的序列。
  • DOI:
    10.1128/mcb.11.12.5977-5984.1991
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    DeZazzo,JD;Falck-Pedersen,E;Imperiale,MJ
  • 通讯作者:
    Imperiale,MJ
Thyrotropin-releasing hormone (TRH) receptor number determines the size of the TRH-responsive phosphoinositide pool. Demonstration using controlled expression of TRH receptors by adenovirus mediated gene transfer.
促甲状腺激素释放激素 (TRH) 受体的数量决定了 TRH 反应性磷酸肌醇库的大小。
  • DOI:
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Gershengorn,MC;Heinflink,M;Nussenzveig,DR;Hinkle,PM;Falck-Pedersen,E
  • 通讯作者:
    Falck-Pedersen,E
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERIK S FALCK-PEDERSEN其他文献

ERIK S FALCK-PEDERSEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERIK S FALCK-PEDERSEN', 18)}}的其他基金

Regulation of host cell inflammatory and maturation response through AdV DNAdete
通过 AdV DNAdete 调节宿主细胞炎症和成熟反应
  • 批准号:
    8286154
  • 财政年份:
    2011
  • 资助金额:
    $ 32.44万
  • 项目类别:
Regulation of host cell inflammatory and maturation response through AdV DNAdete
通过 AdV DNAdete 调节宿主细胞炎症和成熟反应
  • 批准号:
    8477123
  • 财政年份:
    2011
  • 资助金额:
    $ 32.44万
  • 项目类别:
Regulation of host cell inflammatory and maturation response through AdV DNAdete
通过 AdV DNAdete 调节宿主细胞炎症和成熟反应
  • 批准号:
    8686730
  • 财政年份:
    2011
  • 资助金额:
    $ 32.44万
  • 项目类别:
Regulation of host cell inflammatory and maturation response through AdV DNAdete
通过 AdV DNAdete 调节宿主细胞炎症和成熟反应
  • 批准号:
    8084949
  • 财政年份:
    2011
  • 资助金额:
    $ 32.44万
  • 项目类别:
Ad5 Fiber and Penton mts: Influence on immune activation
Ad5 Fiber 和 Penton mts:对免疫激活的影响
  • 批准号:
    7146705
  • 财政年份:
    2004
  • 资助金额:
    $ 32.44万
  • 项目类别:
Ad5 Fiber and Penton mts: Influence on immune activation
Ad5 Fiber 和 Penton mts:对免疫激活的影响
  • 批准号:
    6986149
  • 财政年份:
    2004
  • 资助金额:
    $ 32.44万
  • 项目类别:
Adenovirus Activation of Antigen Presenting Cells Through DNA Sensing Mechanisms
腺病毒通过 DNA 传感机制激活抗原呈递细胞
  • 批准号:
    8105569
  • 财政年份:
    2004
  • 资助金额:
    $ 32.44万
  • 项目类别:
Ad5 Fiber and Penton mts: Influence on immune activation
Ad5 Fiber 和 Penton mts:对免疫激活的影响
  • 批准号:
    6857191
  • 财政年份:
    2004
  • 资助金额:
    $ 32.44万
  • 项目类别:
Ad5 Fiber and Penton mts: Influence on immune activation
Ad5 Fiber 和 Penton mts:对免疫激活的影响
  • 批准号:
    7318336
  • 财政年份:
    2004
  • 资助金额:
    $ 32.44万
  • 项目类别:
Ad5 Fiber and Penton mts: Influence on immune activation
Ad5 Fiber 和 Penton mts:对免疫激活的影响
  • 批准号:
    7534981
  • 财政年份:
    2004
  • 资助金额:
    $ 32.44万
  • 项目类别:

相似海外基金

Mechanisms of messenger RNA splicing and RNA processing regulation
信使RNA剪接和RNA加工调控机制
  • 批准号:
    10623834
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
  • 批准号:
    2246530
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
    Standard Grant
Collaborative Research: Connecting the sequence logic of RNA splicing to nuclear localization
合作研究:将 RNA 剪接的序列逻辑与核定位联系起来
  • 批准号:
    2246531
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
    Standard Grant
Analysis on how RNA splicing factors change global gene expression patterns and regulate male fertility.
分析RNA剪接因子如何改变全局基因表达模式并调节男性生育能力。
  • 批准号:
    2882792
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
    Studentship
Aberrant RNA splicing in sporadic inclusion body myositis
散发性包涵体肌炎中的异常RNA剪接
  • 批准号:
    23K18260
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
用于选择性靶向RNA剪接因子突变型白血病的合成内含子
  • 批准号:
    10722782
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
Cancer immune therapeutics targeting aberrant RNA splicing products
针对异常 RNA 剪接产物的癌症免疫疗法
  • 批准号:
    23H02688
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
RNA splicing regulation during alcohol withdrawal
酒精戒断过程中的 RNA 剪接调节
  • 批准号:
    10785159
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
Targeting Dysregulated RNA Splicing in Neurodegenerative Diseases
靶向神经退行性疾病中失调的 RNA 剪接
  • 批准号:
    10729566
  • 财政年份:
    2023
  • 资助金额:
    $ 32.44万
  • 项目类别:
Srsf3-mediated alternative RNA splicing in craniofacial development
Srsf3介导的颅面发育中的选择性RNA剪接
  • 批准号:
    10650417
  • 财政年份:
    2022
  • 资助金额:
    $ 32.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了